Interferon inducible transcriptional profile in secondary progressive multiple sclerosis patients

被引：0
|
作者：
Gurevich, M. [1 ]
Miron, G. [1 ]
Hanael, E. [1 ]
Sonis, P. [1 ]
Dolev, M. [1 ]
Magalashvili, D. [1 ]
Achiron, A. [1 ]
机构：
[1] Chaim Sheba Med Ctr, Multiple Sclerosis Ctr, Ramat Gan, Israel
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P244
引用
收藏
页码：176 / 176
页数：1
相关论文
共 50 条
  • [21] Interferon beta-1b for treatment of secondary progressive multiple sclerosis
    Zimmermann, C
    Walther, EU
    Goebels, N
    Lienert, C
    Kappos, L
    Hartung, HP
    Hohlfeld, R
    NERVENARZT, 1999, 70 (08): : 759 - 763
  • [22] Interferon-beta 1-b in secondary progressive multiple sclerosis
    Oztekin, N. S.
    Oztekin, M. F.
    Polat, R.
    MULTIPLE SCLEROSIS, 2006, 12 : S193 - S194
  • [23] Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis
    Esposito, Federica
    Radaelli, Marta
    Martinelli, Vittorio
    Sormani, Maria Pia
    Boneschi, Filippo Martinelli
    Moiola, Lucia
    Rocca, Maria Assunta
    Rodegher, Mariaemma
    Comi, Giancarlo
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (12) : 1490 - 1499
  • [24] Epigenetic marks in the brain of patients with secondary progressive multiple sclerosis
    Casaccia, Patrizia
    Mastronardi, Fabrizio
    MULTIPLE SCLEROSIS, 2008, 14 : S60 - S61
  • [25] Chromosomal radiosensitivity in secondary-progressive multiple sclerosis patients
    Petcu, I
    Savu, D
    Vral, A
    Thierens, H
    Nagels, G
    De Ridder, L
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2004, 80 (09) : 663 - 672
  • [26] The efficacy of copaxone therapy in patients with secondary progressive multiple sclerosis
    Zavalishin, I
    Bejn, B
    Sholomov, I
    Alifirova, V
    Poverennova, I
    Baljazin, V
    Okladnikov, V
    Klushin, D
    Peresedova, A
    Stoida, N
    Zaharova, M
    Adarcheva, L
    Nijazbekova, A
    Askarova, L
    Olejnikov, V
    Rebrova, O
    Durseneva, O
    Kuranova, O
    Orlova, J
    Tel'nova, K
    Goncharova, Z
    Volkova, L
    Turova, E
    Okuneva, I
    Nechaeva, J
    Reikhert, L
    Bychenko, S
    Markina, O
    MULTIPLE SCLEROSIS, 2005, 11 : S84 - S84
  • [27] Safety and Tolerability of Siponimod in Patients with Secondary Progressive Multiple Sclerosis
    Fox, Robert
    Kappos, Ludwig
    Bar-Or, Amit
    Cree, Bruce
    Giovannoni, Gavin
    Gold, Ralf
    Vermersch, Patrick
    Pohlmann, Harold
    Wolf, Christian
    Dahlke, Frank
    Wallstrom, Erik
    Sidorenko, Tatiana
    NEUROLOGY, 2017, 88
  • [28] Neurotrophic factors in relapsing-remitting and secondary progressive multiple sclerosis patients during interferon-β therapy
    Caggiula, M
    Batocchi, AR
    Frisullo, G
    Angelucci, E
    Patanella, AK
    Sancricca, C
    Nociti, V
    Tonali, R
    Mirabello, M
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S236 - S236
  • [29] Siponimod in secondary progressive multiple sclerosis
    Rissardo, Jamir Pitton
    Caprara, Ana Leticia Fornari
    INTERNATIONAL ARCHIVES OF HEALTH SCIENCES, 2020, 7 (03) : 155 - 155
  • [30] Natalizumab in secondary progressive multiple sclerosis
    Edan, Gilles
    LANCET NEUROLOGY, 2018, 17 (05): : 384 - 385
12345